by Saska Shepherd | Jan 14, 2022 | Press Release
Cansford Laboratories will be changing the Cansford 9 Common Drug Panel to include Ketamine starting from next month in order to meet a demand in testing from clients. About the Cansford 9 Common Drug Panel The Cansford 9 Common Drug Panel is a test performed on a... 
by Saska Shepherd | Dec 22, 2021 | Press Release
A partnership between Cansford Laboratories and a Cumbrian advisory service has been forged to help early drug and alcohol misuse detection and provide support for those with addictions in Cumbria. Cansford Laboratories has partnered with Cumbria Alcohol and Drug... 
by Saska Shepherd | Sep 14, 2021 | Press Release
We are delighted to announce that James Nutt, Laboratory Operations Manager and Lolita Tsanaclis, Scientific Director and co-founder of Cansford Laboratories are participating in the 2021 prestigious Society of Hair Testing (SoHT) annual meeting in Spain later this... 
by Alex Swann | Sep 1, 2021 | Press Release
As you are probably aware, there is a global issue in the supply of blood collection tubes leading to the NHS reviewing non-essential monitoring through blood tests to ensure a reduction in non-clinically urgent testing. Business as usual The use of blood analysis for... 
by Saska Shepherd | Jul 15, 2021 | Press Release
We are pleased to announce Cansford can now test in-house for a variety of prescription medications, more commonly used to treat clinical depression, anxiety and OCD in individuals. Increasing the scope of testing within these drug groups is in response to specific... 
by Alex Swann | Jun 9, 2021 | Press Release
We are delighted to announce Dr Lolita Tsanaclis, Cansford Laboratories Scientific Director, will be presenting at the 12th Symposium of the European Workplace Drug Testing Society (EWDTS) conference this week (Jun 10th). The prestigious event, due to COVID-19, is...